Chapter 5 - The Forged SignatureCaroline’s eyes widened as she pulled up her personal calendar logs from three years prior. She had been halfway across the world, on a live video conference with Asian healthcare directors, at the exact minute her credentials were used to sign the termination order.
"Who had administrative access to my portal while I was overseas?" Caroline demanded.
David pulled up the historical system access logs. One name appeared on the security bypass override: Gregory Pierce.
At the time, Gregory had been her fiancé and the vice president of corporate acquisitions. He had leveraged her login during her international travel to terminate Project Genesis.
May you like
"Why would he kill a successful cardiac trial?" Caroline murmured, searching the attached financial appendix.
The answer lay in the footnotes: Genesis was an affordable, non-proprietary treatment. Apex Pharma—the very company Gregory was now pushing to merge with—held the patent on an expensive, lifelong cardiac medication. By shutting down Genesis, Gregory cleared the market for Apex Pharma in exchange for millions in offshore stock options.
Related Stories
